1. Home
  2. ICO Base
  3. Luven

Luven

Drugs & Healthcare

Overview

The LUVEN screening test method detects cancer at its early stages with the accuracy of up to 96%.

Features

  • already completed 90% of the project.

Token holders have two opportunities:

  • receiving a part of the company income
  • exchanging their tokens for testing services with a 30% discount, using or selling them to wholesale customers

Technical Details

Ethereum ERC20 standard token.

Crowdsale

Pre-sale
Pre-sale start date 11 Dec 2017
Pre-sale end date 28 Dec 2017
Token Sale
ICO start date 14 Jan 2018
ICO end date 27 Feb 2018
Raised 26,350 USD
Token details
Ticker LVN
Type Utility-token
Additional Token Emission No
Accepted Currencies

ETH

BTC

Bonus Program

At the preICO stage - 3 000 000 tokens (1st day bonus – 30%, 1st week bonus – 25%, 2nd week bonus – 20%, 3d week bonus – 15%)

At the ICO stage - 27 000 000 (1st week – 10%, 1 to 1 onwards)

Referral program 5% purchased by referral

Funds allocation

Clinical trials 40%

Marketing 25%

Software 15%

Legal part 10%

Team remuneration 7%

Bounty campaign 3%

Ratings

Type of scores
Score
Status
Hype score Medium Active

Funding Rounds

Rating Review and Analytics

Investment rating Info NA
Hype score Info Medium
Risk score Info NA

Ended

Raised: $26,350

Start ICO 14 Jan 2018
End ICO 27 Feb 2018
Token LVN
Price 1 LVN = 1 USD
Product Type Service
MVP Ready-to-use full version
KYC No
Whitelist No
Whitepaper View
Luven (LVN) widget
Rating Get this widget
ICOs that might interest you

Status Pending
Hype score High
Risk score Low
Basic Review NA


Status Pending
Hype score High
Risk score Medium
Basic Review NA


Status Pending
Hype score High
Risk score NA
Basic Review NA


Status Pending
Hype score High
Risk score Medium
Basic Review NA